13F filer · CIK 1214717 ↗
Geode Capital Management, LLC
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$712.57B
+8.1% on the quarter before
Positions
4,898
121 new · 252 sold out
Top 10
20.4%
of the value
Est. gain
+$43.81B
on stocks held all quarter
Est. return
+6.7%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Geode Capital Management, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 32% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$782.6MAdded · 4.9% → 4.8%+3,268,917 shares
- Danaher Corp~$422.6MAdded · 0.4% → 0.5%+1,595,344 shares
- Prologis~$411.0MAdded · 0.2% → 0.3%+3,653,101 shares
- Apple~$388.0MAdded · 5.9% → 5.1%+2,991,299 shares
- Amazon~$324.9MAdded · 2.7% → 1.9%+3,875,615 shares
- Copart Inc~$256.8MAdded · 0.1% → 0.1%+4,224,450 shares
- Ferguson Plc~$235.0MNew · 0.0% → 0.0%+1,854,192 shares
- Tesla~$198.4MAdded · 1.9% → 0.8%+1,614,023 shares
- Atlassian Corp -Class A~$198.1MNew · 0.0% → 0.0%+1,539,256 shares
- Home Depot Inc~$184.5MAdded · 0.8% → 0.8%+585,226 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Twitter Inc~$587.1MSold out · 0.1% → 0.0%−13,406,709 shares
- Eli Lilly~$505.3MCut · 0.8% → 0.8%−1,383,789 shares
- Duke Realty Corp~$343.1MSold out · 0.1% → 0.0%−7,127,153 shares
- Abiomed Inc~$251.7MSold out · 0.0% → 0.0%−1,025,568 shares
- Citrix Sys Inc~$239.4MSold out · 0.0% → 0.0%−2,302,805 shares
- Nielsen Holdings Plc~$197.4MSold out · 0.0% → 0.0%−7,126,146 shares
- Brookfield Asset Manage-Cl A~$188.5MSold out · 0.0% → 0.0%−4,569,445 shares
- Biohaven Pharmaceutical Hold~$165.9MSold out · 0.0% → 0.0%−1,097,362 shares
- Alleghany Corp~$149.7MSold out · 0.0% → 0.0%−178,527 shares
- Exxon Mobil Corp~$134.4MCut · 1.0% → 1.1%−1,219,919 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +1.1% · price −6.1% | 5.1% | $36.67B | −$2.34B | ||||||||
| MicrosoftCOM · shares +2.3% · price +2.9% | 4.8% | $34.17B | +$941.5M | ||||||||
| AmazonCOM · shares +2.5% · price −25.7% | 1.9% | $13.54B | −$4.58B | ||||||||
| AlphabetCAP STK CL A · shares +1.7% · price −7.8% | 1.4% | $10.31B | −$860.4M | ||||||||
| Berkshire Hathaway Inc-Cl BCL B NEW · shares +1.3% · price +15.6% | 1.4% | $9.65B | +$1.29B | ||||||||
| Unitedhealth Group IncCOM · shares +1.5% · price +4.9% | 1.3% | $8.92B | +$410.4M | ||||||||
| AlphabetCAP STK CL C · shares +1.0% · price −7.8% | 1.2% | $8.63B | −$721.2M | ||||||||
| Johnson & JohnsonCOM · shares +0.6% · price +8.1% | 1.2% | $8.46B | +$626.5M | ||||||||
| Exxon Mobil CorpCOM · shares −1.6% · price +26.2% | 1.1% | $8.08B | +$1.68B | ||||||||
| Procter & Gamble Co/TheCOM · shares +0.7% · price +20.0% | 0.98% | $7.00B | +$1.16B | ||||||||
| Jpmorgan Chase & CoCOM · shares +2.2% · price +28.2% | 0.96% | $6.86B | +$1.48B | ||||||||
| Visa Inc.COM CL A · shares +2.0% · price +16.9% | 0.94% | $6.68B | +$945.6M | ||||||||
| NvidiaCOM · shares +1.5% · price +20.3% | 0.94% | $6.68B | +$1.11B | ||||||||
| TeslaCOM · shares +3.4% · price −53.6% | 0.85% | $6.04B | −$6.74B | ||||||||
| Home Depot IncCOM · shares +3.2% · price +14.4% | 0.84% | $5.99B | +$730.4M | ||||||||
| Chevron CorpCOM · shares −1.0% · price +24.8% | 0.82% | $5.86B | +$1.17B | ||||||||
| MastercardCL A · shares +1.3% · price +22.2% | 0.79% | $5.66B | +$1.02B | ||||||||
| Pfizer IncCOM · shares −1.1% · price +17.0% | 0.78% | $5.59B | +$812.5M | ||||||||
| Abbvie IncCOM · shares −0.2% · price +20.3% | 0.76% | $5.45B | +$919.9M | ||||||||
| MetaCL A · shares +3.4% · price −11.4% | 0.76% | $5.42B | −$672.5M | ||||||||
| Eli LillyCOM · shares −8.6% · price +13.0% | 0.75% | $5.37B | +$619.7M | ||||||||
| Merck & Co. Inc.COM · shares +0.5% · price +28.7% | 0.75% | $5.35B | +$1.19B | ||||||||
| Coca-Cola Co/TheCOM · shares +0.6% · price +13.5% | 0.68% | $4.82B | +$568.7M | ||||||||
| Pepsico IncCOM · shares +1.1% · price +10.6% | 0.65% | $4.62B | +$437.6M | ||||||||
| BroadcomCOM · shares +2.7% · price +25.8% | 0.58% | $4.15B | +$830.0M | ||||||||
| Total · 4,898 positions | 100% | $712.57B | +$43.81B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 4,773 stocks held throughout, up $43.81B (+6.7%).
- Exxon Mobil Corp+$1.68B+26%
- Jpmorgan Chase & Co+$1.48B+28%
- Berkshire Hathaway Inc-Cl B+$1.29B+16%
- Merck & Co. Inc.+$1.19B+29%
- Chevron Corp+$1.17B+25%
- Alphabet−$721.2M−8%
- Alphabet−$860.4M−8%
- Apple−$2.34B−6%
- Amazon−$4.58B−26%
- Tesla−$6.74B−54%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.88T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.61T−1% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | $1.62T+3% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $1.57T+10% | SEC ↗ |
| Q2 2025 | Aug 8, 2025 | $1.43T+12% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $1.27T−1% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.29T+5% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $1.23T+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $1.14T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.08T+13% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $955.85B+14% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $839.58B−1% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $850.99B+11% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $770.08B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $712.57B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $659.25B−3% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $682.64B−15% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $801.12B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $830.26B+12% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $742.82B+2% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $725.80B+11% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $653.80B+10% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $595.80B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $510.36B+9% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $467.44B+22% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $383.70B−60% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 (amended) | $956.78B+123% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $428.50B+4% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $413.26B+7% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $385.96B−40% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $646.86B+82% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $354.88B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $325.29B+6% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $306.93B+4% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $294.47B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.92B+7% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $254.31B+4% | SEC ↗ |
| Q1 2017 | Jun 21, 2017 (amended) | $243.78B+13% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $215.04B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $198.58B+8% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $183.87B−2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $188.44B | SEC ↗ |